Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report

Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Bayer HealthCare Pharmaceuticals (Bayer Pharma or 'the company'), a business division of Bayer, primarily focuses on the development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women's healthcare. It operates in Europe, the Americas, Asia Pacific, Africa and Middle East. The company is headquartered in Berlin, Germany and employed about 39,000 people as on December 31, 2014.

Scope

– Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis

– An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments

– Intelligence on Bayer Healthcare Pharmaceuticals's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Bayer Healthcare Pharmaceuticals's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Bayer Healthcare Pharmaceuticals: Company Overview

Bayer Healthcare Pharmaceuticals: Overview and Key Facts

Bayer Healthcare Pharmaceuticals: Overview

Bayer Healthcare Pharmaceuticals: Key Facts

Bayer Healthcare Pharmaceuticals: Key Employees

Bayer Healthcare Pharmaceuticals: Key Employee Biographies

Bayer Healthcare Pharmaceuticals: Major Products and Services

Bayer Healthcare Pharmaceuticals: Company History

Bayer Healthcare Pharmaceuticals: Management Statement

Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries

Bayer Healthcare Pharmaceuticals: Key Competitors

Bayer Healthcare Pharmaceuticals: Company Analysis

Bayer Healthcare Pharmaceuticals: Business Description

Bayer Healthcare Pharmaceuticals: SWOT Analysis

Bayer Healthcare Pharmaceuticals: SWOT Overview

Bayer Healthcare Pharmaceuticals: Strengths

Bayer Healthcare Pharmaceuticals: Weaknesses

Bayer Healthcare Pharmaceuticals: Opportunities

Bayer Healthcare Pharmaceuticals: Threats

Bayer Healthcare Pharmaceuticals: Corporate Financial Deals Activity

Bayer Healthcare Pharmaceuticals: Financial Deals Overview

Bayer Healthcare Pharmaceuticals: Targets and Partners

Bayer Healthcare Pharmaceuticals: Top Deals 2013 - 2017YTD*

Bayer Healthcare Pharmaceuticals: Partnership

Bayer Healthcare Pharmaceuticals: Recent Developments

Bayer Healthcare Pharmaceuticals: News and Events Summary

Bayer Healthcare Pharmaceuticals: Corporate Governance

Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events

Bayer Healthcare Pharmaceuticals: Research & Development

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: Bayer Healthcare Pharmaceuticals: Key Facts

Table 2: Bayer Healthcare Pharmaceuticals: Key Employees

Table 3: Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries

Table 4: Bayer Healthcare Pharmaceuticals: Key Competitors

Table 5: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Table 6: Bayer Healthcare Pharmaceuticals: Targets and Partners

Table 7: Bayer Healthcare Pharmaceuticals: Top Deals 2013 – 2017YTD*

Table 8: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2013 – YTD*2017)

Table 9: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2013 – YTD*2017)

Table 10: Bayer Healthcare Pharmaceuticals: News and Events Summary

Table 11: Bayer Healthcare Pharmaceuticals: Corporate Governance

Table 12: Bayer Healthcare Pharmaceuticals: Regulatory and Legal Events

Table 13: Bayer Healthcare Pharmaceuticals: Research & Development

List of Figures

List of Figures

Figure 1: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Figure 2: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2013 – YTD*2017)

Figure 3: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2013 – YTD*2017)

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports